{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:18:22Z","timestamp":1785460702792,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019305","name":"Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Microbes and New Infections"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.nmni.2025.101682","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T06:34:41Z","timestamp":1765089281000},"page":"101682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Engineering Nipah virus: Reverse genetics as a gateway to novel drug discovery"],"prefix":"10.1016","volume":"69","author":[{"given":"Muralidharan Menon","family":"Arjun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0278-8642","authenticated-orcid":false,"given":"Gopinathan Pillai","family":"Sreekanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nmni.2025.101682_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/jmv.24345","article-title":"Origin and evolution of Nipah virus","volume":"88","author":"Lo","year":"2016","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.nmni.2025.101682_bib2","doi-asserted-by":"crossref","first-page":"e1235","DOI":"10.1093\/infdis\/jiae221","article-title":"The genetic diversity of Nipah virus across spatial scales","volume":"230","author":"Cortes-Azuero","year":"2024","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.nmni.2025.101682_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/v15102062","article-title":"Nipah virus: an overview of the Current status of diagnostics and their role in preparedness in endemic countries","volume":"15","author":"Garbuglia","year":"2023","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.nmni.2025.101682_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.soh.2024.100103","article-title":"Nipah virus outbreak trends in Bangladesh during the period 2001 to 2024: a brief review","volume":"4","author":"Bhowmik","year":"2025","journal-title":"Sci One Health"},{"issue":"5","key":"10.1016\/j.nmni.2025.101682_bib5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3201\/eid1705.100968","article-title":"Genomic characterization of Nipah virus, West Bengal, India","volume":"17","author":"Arankalle","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.nmni.2025.101682_bib6","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/infdis\/jiy612","article-title":"Outbreak investigation of Nipah virus disease in Kerala, India, 2018","volume":"219","author":"Arunkumar","year":"2019","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.nmni.2025.101682_bib7","article-title":"Nipah virus outbreaks in Kerala: an impending doom?","volume":"7","author":"Sanker","year":"2024","journal-title":"Health Sci Rep-Us"},{"key":"10.1016\/j.nmni.2025.101682_bib8","article-title":"Twenty-five years of Nipah outbreaks in Southeast Asia: a persistent threat to global health","volume":"13","author":"Khan","year":"2024","journal-title":"IJID Reg"},{"issue":"3","key":"10.1016\/j.nmni.2025.101682_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.12.021","article-title":"Structural and functional analysis of the Nipah virus polymerase complex","volume":"188","author":"Hu","year":"2025","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.nmni.2025.101682_bib10","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.1038\/s41467-024-52701-y","article-title":"Structure of the Nipah virus polymerase phosphoprotein complex","volume":"15","author":"Yang","year":"2024","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.nmni.2025.101682_bib11","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1128\/JVI.02599-08","article-title":"Nipah virus edits its P gene at high frequency to express the V and W proteins","volume":"83","author":"Kulkarni","year":"2009","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.nmni.2025.101682_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bsheal.2022.08.001","article-title":"Reverse genetics in virology: a double edged sword","volume":"4","author":"Chen","year":"2022","journal-title":"Biosaf Health"},{"issue":"1","key":"10.1016\/j.nmni.2025.101682_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/22221751.2019.1571871","article-title":"Nipah pseudovirus system enables evaluation of vaccines and using non-BSL-4 facilities","volume":"8","author":"Nie","year":"2019","journal-title":"Emerg Microb Infect"},{"issue":"4","key":"10.1016\/j.nmni.2025.101682_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10529-023-03351-5","article-title":"Establishment of a neutralization assay for Nipah virus using a high-titer pseudovirus system","volume":"45","author":"Luo","year":"2023","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.nmni.2025.101682_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00842","article-title":"Structure-based design of Nipah virus vaccines: a generalizable approach to Paramyxovirus immunogen development","volume":"11","author":"Loomis","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.nmni.2025.101682_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1031523","article-title":"Assessment of the immunogenicity and protection of a Nipah virus soluble G vaccine candidate in mice and pigs","volume":"13","author":"Gao","year":"2022","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.nmni.2025.101682_bib17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bbrc.2019.03.212","article-title":"Construction of the safe neutralizing assay system using pseudotyped Nipah virus and G protein-specific monoclonal antibody","volume":"513","author":"Bae","year":"2019","journal-title":"Biochem Bioph Res Co"},{"issue":"1","key":"10.1016\/j.nmni.2025.101682_bib18","article-title":"Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.nmni.2025.101682_bib19","article-title":"Potent human neutralizing antibodies against Nipah virus derived from two ancestral antibody heavy chains","volume":"15","author":"Chen","year":"2024","journal-title":"Nat Commun"},{"issue":"23","key":"10.1016\/j.nmni.2025.101682_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.175461","article-title":"Vaccines based on the fusion protein consensus sequence protect Syrian hamsters from Nipah virus infection","volume":"8","author":"Lu","year":"2023","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.nmni.2025.101682_bib21","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1128\/JVI.03050-13","article-title":"Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome Coronavirus and Ebola, Hendra, and nipah viruses by using a novel high-throughput screening assay","volume":"88","author":"Elshabrawy","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.nmni.2025.101682_bib22","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1099\/vir.0.033787-0","article-title":"Mutations in the G-H loop region of ephrin-B2 can enhance Nipah virus binding and infection","volume":"92","author":"Yuan","year":"2011","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.nmni.2025.101682_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.06.003","article-title":"Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses","volume":"91","author":"Hoenen","year":"2011","journal-title":"Antivir Res"},{"issue":"1","key":"10.1016\/j.nmni.2025.101682_bib24","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001944","article-title":"Establishment of a novel minigenome system for the identification of drugs targeting Nipah virus replication","volume":"105","author":"Ke","year":"2024","journal-title":"J Gen Virol"},{"key":"10.1016\/j.nmni.2025.101682_bib25","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1099\/vir.0.83582-0","article-title":"The C, V and W proteins of Nipah virus inhibit minigenome replication","volume":"89","author":"Sleeman","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.nmni.2025.101682_bib26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1099\/vir.0.19685-0","article-title":"Nipah virus conforms to the rule of six in a minigenome replication assay","volume":"85","author":"Halpin","year":"2004","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.nmni.2025.101682_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/v17050707","article-title":"Construction of Minigenome Replicon of Nipah virus and investigation of biological activity","volume":"17","author":"Wang","year":"2025","journal-title":"Viruses-Basel"},{"issue":"3","key":"10.1016\/j.nmni.2025.101682_bib28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.antiviral.2008.07.004","article-title":"Inhibition of Henipavirus infection by RNA interference","volume":"80","author":"Mungall","year":"2008","journal-title":"Antivir Res"},{"issue":"2","key":"10.1016\/j.nmni.2025.101682_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/apb.2022.0037","article-title":"Viral replicon systems and their biosafety aspects","volume":"28","author":"van der Meulen","year":"2023","journal-title":"Appl Biosaf"},{"issue":"31","key":"10.1016\/j.nmni.2025.101682_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh4057","article-title":"Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination","volume":"9","author":"Welch","year":"2023","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.nmni.2025.101682_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2368217","article-title":"Novel transcription and replication-competent virus-like particles system modelling the Nipah virus life cycle","volume":"13","author":"Wang","year":"2024","journal-title":"Emerg Microb Infect"},{"issue":"3","key":"10.1016\/j.nmni.2025.101682_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01821-18","article-title":"Tetherin inhibits nipah virus but not Ebola virus replication in fruit bat cells","volume":"93","author":"Hoffmann","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.nmni.2025.101682_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2013.10.012","article-title":"Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters","volume":"101","author":"Lo","year":"2014","journal-title":"Antivir Res"},{"issue":"44","key":"10.1016\/j.nmni.2025.101682_bib34","doi-asserted-by":"crossref","first-page":"16508","DOI":"10.1073\/pnas.0606972103","article-title":"Establishment of a Nipah virus rescue system","volume":"103","author":"Yoneda","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"10.1016\/j.nmni.2025.101682_bib35","doi-asserted-by":"crossref","first-page":"12777","DOI":"10.1080\/07391102.2023.2175256","article-title":"A study on the design of an in silico self-amplifying mRNA vaccine against Nipah virus using immunoinformatics","volume":"41","author":"Rangacharya","year":"2023","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.nmni.2025.101682_bib36","article-title":"AI-enhanced self-amplifying mRNA vaccine set to combat one of the deadliest known viruses Oslo","year":"2025","journal-title":"Norway: Coalition Epidemic Preparedness Innovations (CEPI)"},{"issue":"1","key":"10.1016\/j.nmni.2025.101682_bib37","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1038\/s41467-021-23779-5","article-title":"A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses","volume":"12","author":"Amarilla","year":"2021","journal-title":"Nat Commun"}],"container-title":["New Microbes and New Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297525001210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297525001210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:46:36Z","timestamp":1778301996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2052297525001210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":37,"alternative-id":["S2052297525001210"],"URL":"https:\/\/doi.org\/10.1016\/j.nmni.2025.101682","relation":{},"ISSN":["2052-2975"],"issn-type":[{"value":"2052-2975","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering Nipah virus: Reverse genetics as a gateway to novel drug discovery","name":"articletitle","label":"Article Title"},{"value":"New Microbes and New Infections","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmni.2025.101682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101682"}}